Oral sulopenem for uncomplicated urinary tract infection launches on US market

口腔医学

来源: urologytimes

原文链接：原文

参考文献

1. Iterum Therapeutics launches ORLYNVAH, the first and only oral penem antibiotic in the U.S. News release. Iterum Therapeutics. August 20, 2025. Accessed August 20, 2025. https://www.iterumtx.com/news/press-releases/detail/155/iterum-therapeutics-launches-orlynvah-the-first-and
2. Dunne MW, Das A, Akinapelli K, Zelasky MT, Boucher HW, Aronin AI. Efficacy and safety of oral sulopenem etzadroxil/probenecid versus oral ciprofloxacin in the treatment of uncomplicated urinary tract infections (uUTI) in adult women: Results from the SURE-1 trial. Presented at: ID Week 2020. October 21, 2020. Accessed August 20, 2025.https://d1io3yog0oux5.cloudfront.net/_c686b74a40042109ff06b21eccc8f678/iterumtx/db/395/2729/pdf/SURE+1+Slide+Presentation+IDweek+2020+19OCT_final.pdf